Stereoselective synthesis of C1-C11 fragment of antitumor cyclodepsipeptide (–)-doliculide by Suryachandra, Dargaiah Kummari et al.
Indian Journal of Chemistry 
Vol. 59B, March 2020, pp. 376-384  
 
 
 
 
 
 
Stereoselective synthesis of C1-C11 fragment of antitumor cyclodepsipeptide (–)-
doliculide 
Dargaiah Kummari Suryachandraa,b, Srinivasarao Tennetia, Nagendrananth Yadavc & J S Yadav*a,d 
a Center for Semiochemicals, CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, India 
b Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201 002, India 
c North Eastern Regional Institute of Science and Technology, Nirjuli 791 109, India 
d School of Science, Indrashil University, Kadi, Mehsana 382 740, India 
E-mail: yadavpub@gmail.com; jsyadav@indrashiluniversity.edu.in 
Received 18 March 2019; accepted (revised) 12 November 2019 
A general and stereoselective synthetic route for C1-C11 polyketide fragment of doliculide has been achieved  
in an efficient manner. The key reactions of our synthetic route are enzymatic desymmetrization of meso-diol, application  
of Evans auxiliary to introduce methyl group, Sharpless asymmetric epoxidation and substrate controlled nucleophilic 
addition reactions. 
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Marine natural products have attracted the attention  
of biologists and chemists worldwide over the past 
few decades1 and have been the source of many 
biologically active compounds and life-saving drugs2. 
Doliculide 1, a marine cytotoxic 16-membered 
cyclodepsipeptide, has been isolated from the 
Japanese sea hare Dolabella auricularia by  
Yamada, et al.3 It consists of a polyketide  
fragment and a substituted D-tyrosine unit. Initially 
the structure of 1 was elucidated by NMR studies,  
and latter its absolute configuration was determined 
by stereoselective total synthesis by Yamada and  
co-workers4. 
Doliculide possesses structural features similar to 
the family of cyclodepsipeptides known as 
geodiamolides and jaspamide5. It is particularly 
unique due to the presence of three alternating syn/syn 
methyl groups, deoxypolypropionate structural unit, 
in the 11-carbon dihydroxy carboxylic acid subunit. 
Deoxypropiontes are structurally integral part of 
many natural products (Figure 1). Such natural 
products exhibit significant biological activities. 
Doliculide is a potent cytotoxic agent against 
HeLa-S3 cells with an IC50 value of 1 ng/mL6. The 
relative importance of specific functional groups in 
doliculide, evaluated by limited structure–activity 
relationship (SAR), has shown that the presence  
of the deoxypolypropionate unit and the iodotyrosine 
motif is essentially important for its cytotoxic 
activity3. The ‘‘hydrocarbon’’ portion is assumed to 
be crucial in conferring a preorganized bioactive 
conformation. The cytotoxicity of doliculide is due to 
its ability to bind with the polymerization of actin in 
developing cells7. Doliculide was shown to be a 
potent and subtype selective antagonist of prostanoid 
E receptor 3 (EP3)8,9. 
In the course of our efforts towards the total 
synthesis of complex natural products10, the structural 
complexity coupled with significant biological 
activity of doliculide tempted us to take up its total 
synthesis. To date, five total syntheses of doliculide 
have been reported3,6,11. In all these earlier reports, 
synthesis of peptide fragment is nearly same but  
that of the crucial polyketide fragment differs 
significantly. 
 
Results and Discussion 
Retrosynthetically, target molecule 1 was 
envisioned to be synthesized from fragments 5 and 6 
through a sequence of esterification followed by 
cycloamidation reaction (Scheme I). Densely 
substituted C1-C11 polyketide fragment 5 was 
synthesised from 9 through enzymatic 
desymmetrization,   Evan’s   asymmetric    alkylation,  
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Figure 1 — Some natural products with “deoxypropionate” structural unit 
 
 
 
Scheme I — Retro synthetic analysis of (–)-doliculide 
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Sharpless asymmetric epoxidation, and substrate 
controlled necleophilic addition reactions. Peptide 
fragment 6 was assumed to be synthesised from 
commercially available D-tyrosine 10. 
Accordingly, we started the synthesis of 5 from 
commercially available starting materials butanone and 
methylmethacrylate (Scheme II). Methylmethacrylate 
and butanone were condensed to obtain  
meso-dimethyl diketone 912. Oxidative cleavage of 
diketone 9 in the presence of NaIO4 furnished  
meso-diacid 1113 which in turn was reduced with 
lithium aluminium hydride to get meso-diol 12. 
Enzymatic desymmetrization of meso-diol 12 with 
Lipase AK and vinyl acetate in THF resulted in the 
formation of chiral alcohol 8 in 74% yield and 95% 
ee14. Protection of hydroxy group as TBS ether 
followed by basic hydrolysis of 8 gave alcohol 13. 
Alcohol 13 was oxidized to aldehyde by swern 
oxidation15 and resulting aldehyde was treated with 
Wittig ylide Ph3PCHCO2Et to obtain α, β-unsaturated 
ester 14 in 86% yield over two steps (Scheme III). 
Reduction of double bond in ester 14 with 
NiCl2.6H2O/NaBH4 followed by base catalyzed 
hydrolysis of ester led to acid 16. Acid 16 was 
coupled with (S)-oxazolidinone in the presence of 
pivaloyl chloride, triethyl amine and lithium chloride 
to obtain compound 1716. Asymmetric methylation17 
of 17 with NaHMDS and CH3I at −78°C followed by 
reduction with NaBH4 resulted into syn/syn 
deoxypolypropionate intermediate 19 in 88% yield. 
With crucial intermediate 19 in our hand, now 
stage is set for the introduction of 1,3-anti diol 
stereocenters at C7 and C9 through Sharpless 
asymmetric epoxidation and substrate controlled 
nucleophilic addition. The hydroxyl group in 
compound 19 (Scheme IV) was protected as its PMB 
ether using PMB imidate followed by the deprotection 
of TBS group to end up with alcohol 20 in 97% yield. 
 
 
Scheme II — (a) NaOMe, Xylene/Benzene, 0°C, 33%; (b) NaIO4, H2O, 96%; (c) LiAlH4, THF, 97%; (d) Lipase AK, Vinyl acetate, 74%,
95% ee; (e) i.TBSCl, imidazole, CH2Cl2, 0°C to RT; ii. NaOMe, MeOH, RT, 96% over two steps. 
 
 
 
Scheme III — (a) i. (COCl)2, DMSO,CH2Cl2, −78°C; ii. Ph3PCHCO2Et, CH2Cl2, RT, 86%; (b) NiCl2.6H2O/NaBH4, MeOH 90%; 
(c) LiOH·H2O, MeOH:H2O (4:1) 93%; (d) (S)-oxazolidinone, PivCl, Et3N, LiCl, THF, −20°C to 0°C, 93%; (e) NaHMDS, CH3I, 
THF, −78°C, 91%; (f) NaBH4, MeOH, 0°C to RT, 92%. 
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The alcohol 20 was oxidized to aldehyde and  
the resulting aldehyde was treated with C2-Wittig 
ylide to get ester 21 in 86% yield. Ester 21 was 
reduced to allylic alcohol 22 using DIBAL-H.  
Allylic alcohol 22 was subjected to Sharpless 
asymmetric epoxidation conditions18 to obtain 
epoxide 23 in 85% yield. Epoxy alcohol 23 was 
regioselectively opened with Red-Al to obtain  
1,3-diol 24. The 1,3-diol 24 was immediately 
converted to di-TBS ether 25 using TBSCl in 90% 
yield, and primary TBS group was selectively 
deprotected with HF·Pyridine to furnish alcohol 26 in 
85% yield. The alcohol 26 was oxidized to aldehyde 
by Swern oxidation and treated with freshly prepared 
isopropyl magnesium bromide at −78°C to get desired 
fragment 5 in 55% yield. The mixture of (anti/syn, 
80:20) isomers were easily separable in column 
chromatography. The preference for anti selectivity 
can be explained through the formation of transition 
state driven by chelation control19. 
 
Experimental Section 
All reactions were performed under inert 
atmosphere, if argon mentioned. All glass  
apparatus used for reactions were perfectly 
oven/flame dried. Anhydrous solvents were distilled 
prior to use: THF from Na and benzophenone; 
CH2Cl2, DMSO from CaH2; MeOH from Mg cake. 
Commercial reagents were used without purification. 
Column chromatography was carried out over silica 
gel (60–120 mesh) unless otherwise mentioned. 
Analytical thin layer chromatography (TLC) was run 
on silica gel 60 F254 pre-coated plates (250 μm 
thickness). Optical rotations [α]D were measured on a 
polarimeter and given in 10−1 degcm2g−1. Infrared 
spectra were recorded in CHCl3/KBr (as mentioned) 
and reported in wave number (cm−1). Mass spectral 
data were obtained using MS (EI) ESI, HRMS mass 
spectrometers. 1H NMR spectra were recorded at 300, 
400, 500, 600 and 13C NMR spectra at 75 MHz in 
CDCl3 solution unless otherwise mentioned. Chemical 
shifts are in δ (ppm) downfield from tetramethylsilane 
and coupling constants (J) are reported in Hertz (Hz). 
The following abbreviations are used to designate 
signal multiplicity: s = singlet, d = doublet, t = triplet, 
q = quartet, m = multiplet, br = broad. 
 
(2S,4R)-5-Hydroxy-2,4-dimethylpentyl acetate, 
8: To a stirred solution of meso-diol 12 (4.0 g, 30.30 
mmol, 1.0 equiv.) in THF (40 mL) was cooled to 0°C. 
At this temperature, Amano Lipase AK (220 mg)  
and vinyl acetate (4.20 mL, 3.90 g, 45.4 mmol,  
1.50 equiv) were added. The reaction mixture was 
stirred for 30 min at 0°C and 7 h at 5°C. The enzyme 
was removed by suction filtration through Celite. The 
residue was further washed with diethyl ether (2 × 
30 mL) and dried over Na2SO4. The homogeneous 
filtrate was concentrated in vacuo and purified by 
chromatography on silica gel (1:5, EtOAc/hexane) to 
afford the monoacetate 8 (3.902 g, 74%). [α]D25 + 9.8° 
 
 
Scheme IV — (a) PMBOC(=NH)CCl3, PPTS, CH2Cl2/C6H12, 76%; (b) TBAF, THF, 97%; (c) i. (COCl)2, DMSO, CH2Cl2, −78°C; 
ii. Ph3PCHCO2Et, CH2Cl2, RT, 86%; (d) DIBAL-H, CH2Cl2,0°C, 2 h, 90%; (e) (–)-DET, CH2Cl2, Ti(OiPr)4, TBHP, −20°C, 12 h, 85%; 
(f) Red Al, dry THF, 0°C, 3 h, 84%; (g) TBSCl, imidazole, CH2Cl2, RT, 24 h, 90%; (h) HF·Pyridine, THF, 4 h, 0°C, 85%; (i) i. (COCl)2, 
DMSO, CH2Cl2, −78°C; ii. Isopropyl bromide, Mg(s), THF, −78°C to 20°C, 55%. 
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(c 0.6, CHCl3); 1H NMR (CDCl3, 300 MHz): δ 3.97 
(dd, J = 10.5, 5.2 Hz, 1H), 3.85 (dd, J = 10.5, 6.7 Hz, 
1H), 3.49 (dd, J = 10.5, 6.0 Hz, 1H), 3.42 (dd, J = 10.5, 
6.0 Hz, 1H), 2.05 (s, 3H), 1.96-1.82 (m, 1H), 1.78-
1.64 (m, 1H), 1.43 (br, s, 1H), 1.49-1.39 (m, 1H), 
1.30-1.15 (m, 1H), 0.96 (d, J = 6.7 Hz, 3H), 0.95  
(d, J = 6.7 Hz, 3H); 13C NMR (CDCl3, 75 MHz): δ 
171.3, 69.1, 67.9, 37.2, 32.9, 29.9, 20.9, 17.8, 17.2. 
(2S,4R)-5-(tert-Butyldimethylsilyloxy)-2,4-dimeth- 
ylpentan-1-ol, 13: To a cold (0°C) solution  
of alcohol 8 (5.0 g, 28.7 mmol) in anhydrous CH2Cl2 
(80 mL) was added imidazole (3.9 g, 57.4 mmol) and 
tert-butyldimethylsilylchloride (5.16 g, 34.4 mmol). 
The resulting mixture was stirred at RT for 3 h. After 
completion of the reaction as indicated by TLC,  
the mixture was quenched with saturated aqueous 
NH4Cl solution (5 mL) and extracted with CH2Cl2  
(3 × 50 mL). The combined organic layers were 
washed with brine (5 mL), dried over Na2SO4 and 
concentrated under reduced pressure to furnish crude 
acetate. To the above mixture in MeOH (80 mL) was 
added sodium methoxide (2.3 g, 43.05 mmol) at RT. 
Then the mixture was stirred for 1 h at RT and 
concentrated under reduced pressure. The residue was 
then quenched by the addition of saturated NH4Cl and 
extracted with EtOAc (3 × 100 mL). The combined 
organic layers were washed with water, brine, dried 
over Na2SO4 and concentrated in vacuum. The 
resulting crude product was purified by silica gel 
column chromatography (1:9 EtOAc/hexane) to give 
the product as a colorless oil 13 in (6.77 g, 96%) 
yield. Rf = 0.4 (10% EtOAc/hexane). [α]D25: + 0.9°  
(c 1.2, CHCl3); IR (Neat): 3348, 2954, 2928, 2857, 
1466, 1252, 1097, 837, 775 cm−1; 1H NMR (CDCl3, 
300 MHz): δ 3.50-3.32 (m, 4H), 1.77-1.60 (m, 2H), 
1.50-1.36 (m, 2H), 0.93 (d, J = 6.7 Hz, 3H), 0.90  
(d, J = 6.7 Hz, 3H), 0.89 (s, 9H), 0.03 (s, 6H); 
13C NMR (CDCl3, 75 MHz): δ 68.2, 67.9, 37.2, 33.1, 
25.8, 18.2, 17.7, 17.6, −5.4. 
(4S,6R,E)-Ethyl 7-(tert-butyldimethylsilyloxy)-
4,6-dimethylhept-2-enoate, 14: To a stirred solution 
of oxalyl chloride (3.43 mL, 40.5 mmol) in dry 
CH2Cl2 (20 mL) at –78°C, was added DMSO  
(4.32 mL, 60.8 mmol) drop-wise under nitrogen 
atmosphere. After 15 min stirring, a solution of 
alcohol 13 (5 g, 20.28 mmol) in 20 mL of dry CH2Cl2 
was added. After 45 min of stirring at –78°C, Et3N 
(17 mL, 122 mmol) was added and the mixture was 
stirred for 0.5 h at –78°C and then for 0.5 h at 0°C. 
The mixture was then quenched with sat. NH4Cl 
solution (30 mL) and extracted with CH2Cl2 (2 ×  
100 mL). The combined organic layers were washed 
with water (100 mL), followed by brine (100 mL) 
solution, dried over Na2SO4, and concentrated 
in vacuo. To the above crude mixture (4.94 g,  
20.1 mmol) in CH2Cl2 (150 mL) was added 
(ethoxycarbonylmethylene) triphenyl phosphorane 
(17.0 g, 48.9 mmol) and resulting mixture was stirred 
for 12 h at RT. The reaction mixture was concentrated 
under reduced pressure and purified on silica gel 
chromatography (5% EtOAc/hexane) to afford the 
unsaturated ester 14 (7.3 g, 86% over two steps) as a 
colourless liquid. Rf = 0.5 (10% EtOAc/hexane). 
[α]D25: +17.9° (c = 1.0 in CHCl3); IR (Neat): 2957, 
2859, 1722, 1652, 1465, 1367, 1259, 1180, 1094, 
1042, 840, 775 cm−1; HRMS (ESI): Calcd for 
C17H34O3NaSi: 337.2174. Found: 337.2174; 1H NMR 
(CDCl3, 300 MHz): δ 6.76 (dd, J = 15.8, 8.3 Hz, 1H), 
5.75 (d, J = 15.8 Hz, 1H), 4.17 (q, J = 14.3, 6.7 Hz, 
2H), 3.37 (dd, J = 5.2, 1.5 Hz, 2H), 2.51-2.32 (m, 1H), 
1.67-1.44 (m, 2H), 1.29 (t, J = 6.7 Hz, 3H), 1.15-1.06 
(m, 1H), 1.06 (d, J = 6.7 Hz, 3H), 0.89 (s, 9H), 0.86 
(d, J = 6.7 Hz, 3H), 0.03 (s, 6H); 13C NMR (CDCl3, 
75 MHz): δ 166.7, 154.3, 119.7, 68.3, 60.0, 39.8, 
34.1, 33.3, 25.8, 20.4, 18.2, 16.5, 14.2, −5.4. 
(4R,6R)-Ethyl 7-(tert-butyldimethylsilyloxy)-4,6-
dimethylheptanoate, 15: To a cooled (0°C) solution 
of 14 (7.2 g, 22.9 mmol) and NiCl2.6H2O (1.08 g, 
4.58 mmol) in MeOH (100 mL), was added NaBH4 
(2.0 g, 54.9 mmol) in small portions to the solution. 
During addition of NaBH4, the reaction temperature 
was maintained at 0°C. After complete addition of 
NaBH4, the reaction mixture was stirred for 1 h at RT 
and the resulting black precipitate was filtered and 
then washed with MeOH. The solvent was removed 
under reduced pressure and then diluted with water 
(100 mL) and extracted with ethyl acetate (3 × 100 mL). 
The combined organic layers were washed with 
water, brine and dried over anhydrous Na2SO4. 
Removal of solvent under reduced pressure followed 
by purification on silica gel column chromatography 
using ethyl acetate/hexane (5% EtOAc/hexane) gave 
the product 15 (6.9 g, 96% yield) as a colorless oil. Rf 
= 0.5 (10% EtOAc/hexane). [α]D25: +3.8° (c = 1.2 in 
CHCl3); IR (Neat): 2956, 1738, 1636, 1253, 1094, 
772, 570 cm−1; HRMS (ESI): Calcd for 
C17H36O3NaSi: 339.2331. Found: 339.2321; 1H NMR 
(CDCl3, 300 MHz): δ 4.10 (q, J = 14.3, 6.7 Hz, 2H), 
3.41 (dd, J = 9.8, 6.0 Hz, 1H), 3.33 (dd, J = 9.8,  
6.0 Hz, 1H), 2.34-2.18 (m, 2H), 1.75-1.28 (m, 6H), 
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1.26 (t, J = 6.7 Hz, 3H), 0.90 (d, J = 6.0 Hz, 3H), 0.89 
(s, 9H), 0.87 (d, J = 6.0 Hz, 3H)), 0.02 (s, 6H); 
13C NMR (CDCl3, 75 MHz): δ 174.0, 68.2, 60.1, 40.7, 
33.0, 31.8, 31.5, 29.6, 25.9, 20.0, 18.2, 17.3, 14.2, −5.4. 
(4R,6R)-7-(tert-Butyldimethylsilyloxy)-4,6-dimeth- 
ylheptanoic acid, 16: LiOH·H2O (2.7 g,  
64.5 mmol) was added portion wise to a cooled 
solution (0°C) of ester 15 (6.8 g, 21.5 mmol) in  
80 mL of CH3OH:H2O (4:1) and the stirring was 
continued for 2 h at RT. The reaction mixture was 
then concentrated in vacuum and the residue was 
diluted with EtOAc (80 mL) and washed with 
saturated NH4Cl solution (10 mL) and extracted with 
EtOAc (3 × 50 mL). The combined organic layers 
were washed with brine, dried over Na2SO4 and 
concentrated under reduced pressure. Removal of 
solvent followed by column chromatography  
using 20% EtOAc/hexane afforded the acid 16 (5.7 g, 
93% yield) as a colorless liquid. Rf = 0.3 (10% 
EtOAc/hexane). [α]D25: +5.0° (c = 0.7 in CHCl3);  
IR (Neat): 2956, 2930, 2858, 1711, 1464, 1414,  
1253, 1094, 938, 839, 775, 667 cm−1; HRMS (ESI): 
Calcd for C15H32O3NaSi: 311.2018. Found: 311.2028; 
1H NMR (CDCl3, 300 MHz): δ 3.45-3.30 (m, 2H), 2.42-
2.24 (m, 2H), 1.78-1.06 (m, 6H), 0.92 (d, J = 6.7 Hz, 
3H), 0.89 (s, 9H), 0.88 (d, J = 6.7 Hz, 3H)), 0.03 (s, 6H); 
13C NMR (CDCl3, 75 MHz): δ 180.2, 68.1, 40.6, 33.0, 
31.5, 31.2, 29.6, 25.9, 19.9, 18.3, 17.4, −5.3. 
(4R)-4-Benzyl-3-((4R,6R)-7-(tert-butyldimethyl-
silyloxy)-4,6-dimethylheptanoyl) dihydrofuran-
2(3H)- one, 17: To a stirred solution of acid 16 (5.6 g, 
19.4 mmol) in THF (100 mL) at −20°C was  
added Et3N (6.74 mL, 48.5 mmol) followed by  
PivCl (2.4 mL, 19.4 mmol). After stirring for 1 h  
at –20°C, LiCl (1.23 g, 29.1 mmol) followed by (S)-
oxazolidinone (3.77 g, 21.3 mmol) were added to it at 
the same temperature. The stirring was continued for 
1 h at −20°C and then 2 h at 0°C. It was then 
quenched with saturated NH4Cl solution (50 mL) and 
extracted with ethyl acetate (2 × 80 mL). The 
combined organic layers were washed with brine  
(30 mL), dried over anhydrous Na2SO4 and 
concentrated under reduced pressure. The crude 
product was purified by silica gel column 
chromatography using ethyl acetate and hexane (1:16) 
to gave 17 (8.0 g, 93%) as a viscous liquid. Rf = 0.5 
(10% EtOAc/hexane). [α]D25: +38.8° (c = 1.0 in 
CHCl3); IR (Neat): 2954, 2928, 2857, 1784, 1700, 
1461, 1386, 1353, 1251, 1208, 1093, 839, 772, 701, 
591cm−1; HRMS (ESI): Calcd for C25H41NO4Si Na: 
470.2702. Found: 470.2714; 1H NMR (CDCl3,  
300 MHz): δ 7.38-7.15 (m, 5H), 4.67-4.54 (m, 1H), 
4.23-4.09 (m, 2H), 3.43 (dd, J = 9.8, 5.2 Hz, 1H), 3.40-
3.25 (m, 2H), 3.03-2.78 (m, 2H), 2.69 (dd, J = 13.5,  
9.8 Hz, 1H), 1.80-1.08 (m, 6H), 0.95 (d, J = 6.0 Hz, 3H), 
0.89 (s, 9H), 0.88 (d, J = 6.7 Hz, 3H), 0.03 (s, 6H); 
13C NMR (CDCl3, 75 MHz): δ 173.6, 153.3, 135.3, 
129.3, 128.8, 127.2, 68.2, 66.0, 55.1, 40.8, 37.8, 33.1, 
33.0, 30.8, 29.7, 25.9, 20.0, 18.3, 17.4, −5.3. 
(4R)-4-Benzyl-3-((2S,4S,6R)-7-(tert-butyldimethyl-
silyloxy)-2,4,6-trimethylheptanoyl) dihydrofuran-
2(3H)-one, 18: To a stirred solution of 17 (4.0 g,  
8.9 mmol) in anhydrous THF (80 mL) at −78°C, 
NaHMDS (1M solution in THF, 13.35 mL, 13.35 mmol) 
was added slowly dropwise with stirring under 
nitrogen atmosphere. After stirring at −78°C for  
30 min, MeI (1.56 mL, 26.7 mmol) was added 
dropwise to the reaction mixture and then stirring was 
continued for another 2 h at −78°C. Then the mixture 
was quenched with saturated NH4Cl (50 mL) and 
warmed to RT and then extracted with ethyl acetate 
(2× 100 mL). The combined organic extracts were 
washed with brine (50 mL), dried over anhydrous 
Na2SO4 and concentrated under reduced pressure. The 
crude product was purified by silica gel column 
chromatography using ethyl acetate and hexane (1:19) 
to afford the product 18 as a colorless liquid (3.73 g, 
91%). Rf = 0.6 (10% EtOAc/hexane). [α]D25: +41.6°  
(c = 1.3 in CHCl3); IR (Neat): 2954, 2928, 2857, 
1784, 1700, 1461, 1386, 1353, 1251, 1208, 1093, 839, 
772, 701, 591cm−1; HRMS (ESI): Calcd for C26H43O4 
Si Na: 484.2859. Found: 484.2875; 1H NMR (CDCl3, 
300 MHz): δ 7.37-7.17 (m, 5H), 4.68-4.55 (m, 1H), 
4.22-4.08 (m, H), 3.93-3.77 (m, 1H), 3.47-3.22  
(m, 3H), 2.70 (dd, J = 12.8, 9.8 Hz, 1H), 1.98-1.25 
(m, 5H), 1.20 (d, J = 6.7 Hz, 3H), 1.12-0.96 (m, 1H), 
0.89 (s, 9H), 0.88 (d, J = 6.7 Hz, 6H), 0.03 (s, 6H); 
13C NMR (CDCl3, 75 MHz): δ 177.2, 152.9, 135.2, 
129.4, 128.8, 127.2, 68.3, 65.9, 55.2, 41.2, 40.4, 37.8, 
35.2, 33.0, 28.1, 25.9, 20.7, 18.5, 18.3, 17.4, −5.3. 
(2S,4R,6R)-7-(tert-Butyldimethylsilyloxy)-2,4,6-
trimethylheptan-1-ol, 19: To a stirred solution  
of 18 (5.0 g, 10.8 mmol) in MeOH (40 mL) at 0ºC 
was added NaBH4 portion wise (1.23 g, 32.4 mmol). 
The reaction mixture was allowed to stir for  
1 h at same temperature and then quenched  
with saturated NH4Cl solution. The solvent was 
removed under reduced pressure and the resulting 
residue was diluted with water and extracted with 
EtOAc (3 × 100 mL). The combined organic layers 
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were dried over Na2SO4 and concentrated  
under reduced pressure and the crude product was 
purified by silica gel column chromatography  
(10%, EtOAc/hexane) to afford the pure product 19 
(2.86 g, 92%) as a viscous liquid. Rf = 0.5 (10% 
EtOAc/hexane). [α]D25: 5.8° (c = 1.0 in CHCl3); IR 
(Neat): 3351, 2956, 2928, 2858, 1465, 1383, 1253, 
1098, 1040, 838, 775, 667 cm−1; HRMS (ESI): Calcd 
for C16H36O2 Si Na: 311.2382. Found: 311.2398; 
1H NMR (CDCl3, 300 MHz): δ 3.55-3.29 (m, 4H), 
2.60 (s, 1H), 1.88-0.96 (m, 7H), 0.93 (d, J = 7.5 Hz, 
3H), 0.90 (d, J = 6.7 Hz, 3H), 0.89 (s, 9H), 0.88 (d,  
J = 6.7 Hz, 3H), 0.03 (s, 6H); 13C NMR (CDCl3,  
75 MHz): δ 68.1, 67.9, 41.2, 41.0, 33.0, 27.6, 25.9, 
21.0, 18.3, 17.9, 17.5, −5.3. 
tert-Butyl(((2R,4R,6S)-7-((4-methoxybenzyl)oxy)-
2,4,6-trimethylheptyl)oxy)dimethylsilane, 7:  
p-Methoxybenzyl trichloroacetimidate (9.79g,  
34.66 mmol) and PPTS (435 mg, 1.73 mmol) were 
added over 5 min to a solution of compound 19  
(2g, 6.93 mmol) in CH2Cl2/cyclohexane (1/2, 80 mL) 
at 0°C. The reaction mixture was stirred at ambient 
temperature for 48 h before it was filtered through a 
pad of Celite. The filtrate was evaporated and the 
residue was purified by flash chromatography 
(hexanes/ethyl acetate, 40/2) to give the title 
compound 7 as a colorless oil (2.2g, 78%). 1H NMR 
(CDCl3, 300 MHz): δ 7.39-7.5 (m, 2H), 7.01-7.07  
(m, 2H), 4.55-4.84 (m, 2H), 3.97 (s, 3H), 3.62 (dd,  
J = 9.8, 4.5 Hz, 1H), 3.45-3.52 (m, 2H), 3.32 (dd,  
J = 9.1, 7.5 Hz, 1H), 1.96-2.1 (m, 1H), 1.68-1.91  
(m, 3H), 1.41-1.56 (m, 2H), 0.94-1.11 (m, 19H), 0.2 
(s, 6H); 13C NMR (CDCl3, 75 MHz): δ 129.0, 113.6, 
75.6, 72.5, 68.0, 55.1, 41.7, 41.0, 33.0, 30.8, 27.6, 
25.9, 21.0, 18.2, 17.9, −5.4. 
(2R,4S,6S)-7-((4-Methoxybenzyl)oxy)-2,4,6-tri- 
methylheptan-1-ol, 20: A solution of TBAF in THF 
(1 M, 28.9 mL, 28.9 mmol) was added dropwise to a 
solution of compound 7 (2.2 g, 5.38 mmol) in THF 
(60 mL). After stirring for 3 h, the reaction was 
quenched with sat. aq. NH4Cl (30 mL) and diluted 
with tert-butyl methyl ether and water. The aqueous 
layer was extracted with tert-butyl methyl ether and 
the combined organic phases were dried over Na2SO4, 
filtered and evaporated. Flash chromatography 
(hexanes/ethyl acetate, 2/1) of the residue provided 
the title alcohol 20 as a colorless oil (1.53 g, 97%). 
1H NMR (CDCl3, 300 MHz): δ 7.23-7.28 (m, 2H), 
6.85-6.9 (m, 2H), 4.38-4.47 (m, 2H), 3.81 (s, 3H), 
3.52 (dd, J = 10.5, 5.3 Hz, 1H), 3.25-3.41 (m, 2H), 
3.18 (dd, J = 9.0, 7.5 Hz, 1H), 1.78-1.90 (m, 1H), 
1.49-1.78 (m, 3H), 1.23-1.39 (m, 3H), 0.86-0.97 (m, 
9H); 13C NMR (CDCl3, 75 MHz): δ 158.9, 130.7, 
129.0, 113.5, 75.4, 72.5, 67.9, 55.1, 41.5, 41.0, 32.9, 
30.8, 27.5, 20.9, 18.3, 17.5. 
Ethyl (4R,6S,8S,E)-9-((4-methoxybenzyl)oxy)-
4,6,8-trimethylnon-2-enoate, 21: To a stirred 
solution of oxalyl chloride (0.6 mL, 6.8 mmol)  
in dry CH2Cl2 (20 mL) at −78°C, was added DMSO 
(0.73 mL, 10.2 mmol) drop-wise under nitrogen 
atmosphere. After 15 min stirring, a solution of 
alcohol 20 (1.0g, 3.4 mmol) in 20 mL of dry CH2Cl2 
was added. After 45 min of stirring at −78°C, Et3N 
(2.8 mL, 20.4 mmol) was added and the mixture was 
stirred for 0.5 h at −78°C and then for 0.5 h at 0°C. 
The mixture was then quenched with sat. NH4Cl 
solution (30 mL) and extracted with CH2Cl2 (2 ×  
100 mL). The combined organic layers were washed 
with water (100 mL), followed by brine (100 mL) 
solution, dried over Na2SO4, and concentrated 
in vacuo. To a stirred solution of the above crude 
aldehyde in benzene was added stabilized ylide, 
Ph3PCHCO2Et (2.62g, 6.12 mmol) and the mixture 
was allowed to reflux for 2 h. It was then concentrated 
in vacuo. Purification of the crude ester by column 
chromatography on silica gel (1:9 EtOAc/hexane) 
gave the pure unsaturated ester 21 (1.06g, 86%  
over two steps) as a colourless liquid. 1H NMR 
(CDCl3, 300 MHz): δ 7.25 (d, J = 8.309 Hz, 2H), 6.88 
(d, J = 8.3 Hz, 2H), 6.8 (dd, J = 15.8, 8.3 Hz, 1H), 
5.78 (d, J = 15.8 Hz, 1H), 4.37-4.46 (m, 2H), 4.18 (qt, 
J = 7.5 Hz, 2H), 3.8 (s, 3H), 3.28 (dd, J = 9.0, 5.2 Hz, 
1H), 3.17 (dd, J = 9.0, 6.7 Hz, 1H), 2.34-2.49  
(m, 1H), 1.75-1.89 (m, 1H), 1.45-1.57 (m, 1H), 1.26-1.43 
(m, 3H), 1.28 (t, J = 7.5 Hz, 3H), 1.05-1.13  
(m, 1H), 1.02 (d, J = 6.7 Hz, 3H), 0.89 (d, J = 6.7 Hz, 
3H), 0.86 (d, J = 6.0 Hz, 3H); 13C NMR (CDCl3, 75 
MHz): δ 166.6, 158.8, 154.3, 130.6, 128.9, 119.6, 
113.5, 75.5, 72.4, 59.9, 55.0, 43.3, 41.7, 34.0, 30.5, 
27.6, 20.3, 20.0, 17.7, 14.1. 
(4R,6S,8S,E)-9-((4-Methoxybenzyl)oxy)-4,6,8-tri- 
methylnon-2-en-1-ol, 22: To a stirred solution  
of ester 21 (1g, 2.75 mmol) in dry dichloromethane 
(15 mL) at 0°C was added a solution of DIBAL-H 
(8.3 mL of 1.0 M solution in toluene, 8.27 mmol) 
drop-wise. The resulting mixture was stirred for 1 h at 
RT and then quenched with methanol and sat.sodium 
potassium tartarate solution (15 mL) at 0°C. The 
organic layer was washed with brine, dried over 
anhydrous Na2SO4 and purified by column 
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chromatography (3:7, EtOAc/hexane) to give the  
allyl alcohol 22 (800 mg, 90%) as oil. 1H NMR 
(CDCl3, 300 MHz): δ 7.25 (dd, J = 8.6, 2.6 Hz, 2H), 
6.88 (d, J = 8.6 Hz, 2H), 5.6 (dt, J = 15.4, 5.4 Hz, 
1H), 5.46 (dd, J = 15.4, 7.9 Hz, 1H), 4.37-4.47 (m, 
2H), 4.06 (d, J = 5.4 Hz, 2H), 3.8 (s, 3H), 3.28 (dd, 
J = 9.0, 5.4 Hz, 1H), 3.17 (dd, J = 8.8, 6.7 Hz, 1H), 
2.16-2.33 (m, 1H), 1.83 (m, 1H), 1.43-1.56 (m, 1H), 
1.21-1.35 (m, 3H), 0.9-1.03 (m, 2H), 0.96 (d, J = 6.6 Hz, 
3H), 0.89 (d, J = 6.6 Hz, 3H), 0.85 (d, J = 6.6 Hz, 3H); 
13C NMR (CDCl3, 75 MHz): δ 158.9, 138.7, 130.7, 
129.0, 127.4, 113.5, 75.7, 72.5, 63.6, 55.1, 44.1, 41.8, 
33.9, 30.6, 27.6, 21.5, 20.3, 17.8. 
((2R,3R)-3-((2R,4R,6S)-7-((4-Methoxybenzyl)oxy)-
4,6-dimethylheptan-2-yl)oxiran-2yl) methanol, 23: 
To a stirred suspension of powdered 4 Å molecular 
sieves in CH2Cl2 (8 mL) at −20°C were added L-(–)-
DET (16 µL, 0.86 mmol) and Ti(O-iPr)4 (22 µL, 0.69 
mmol). After 30 min, a solution of allylic alcohol 22 
(200 mg, 0.62 mmol) in CH2Cl2 (5 mL) was added to 
the above suspension, and then 5M TBHP in toluene 
(0.24 mL, 1.25 mmol) was added. The resulting 
mixture was stirred at −20°C for 6 h and then 
quenched with H2O (6 mL). The above mixture was 
treated with 3M NaOH and then saturated with solid 
NaCl and the resulting mixture was stirred vigorously 
for 30 min. The layers were separated, and the 
aqueous layer was extracted with CH2Cl2 (3 × 10 mL). 
The combined organic layers were dried (Na2SO4) 
and concentrated under reduced pressure. The crude 
product was purified by column chromatography 
(EtOAc–n-hexane, 3:7) to afford the epoxy alcohol  
23 (175 mg, 85%) as a colorless liquid. 1H NMR 
(CDCl3, 300 MHz): δ 7.26 (d, J = 7.5 Hz, 2H), 6.88 
(d, J = 7.5 Hz, 2H), 4.36-4.47 (m, 2H), 3.82-3.94  
(m, 1H), 3.81 (s, 3H), 3.54-3.64 (m, 1H), 3.30 (dt,  
J = 13.5, 3.7 Hz, 1H), 3.19 (dd, J = 9.0, 6.7 Hz, 1H), 
2.88-2.98 (m, 1H), 2.63-2.75 (m, 1H), 1.70.1.91  
(m, 2H), 1.26-1.63 (m, 3H), 0.81-1.10 (m, 11H). 
(S)-5-((2R,4R,6S)-7-((4-Methoxybenzyl)oxy)-4,6-
dimethylheptan-2-yl)-2,2,3,3,9,9,10,10-octamethyl-
4,8-dioxa-3,9-disilaundecane, 26: To a stirred 
solution of compound 23 in THF was added Red-Al 
(1M in THF) at 0°C after completion of starting 
material 23 the reaction mixture was quenched with 
aq. solution of NH4Cl, extracted with EtOAc and 
organic layer was concentrated under reduced 
pressure to give crude 1,3-diol 24 which was 
subjected to further reaction without purification. To a 
solution of 24 (100 mg, 0.29 mmol) in dry CH2Cl2  
(8 mL) was added imidazole (60 mg, 0.89 mmol) in 
one portion and stirred for 30 minutes at 0°C followed 
by tert-butyldimethylsilyl chloride. The reaction 
mixture was stirred for 6-12 h with the temperature 
slowly reaching RT. It was quenched with the 
saturated NH4Cl solution (8 mL), diluted with EtOAc 
(10 mL), washed with brine (15 mL), dried (Na2SO4) 
and concentrated in vacuo. Purification of the  
crude product by column chromatography afforded  
25 (134 mg, 80%) as a colorless liquid. 1H NMR 
(CDCl3, 500 MHz): δ 7.25 (d, J = 8.8 Hz, 2H), 6.87 
(d, J = 7.6 Hz, 2H), 4.38-4.45 (m, 2H), 3.8 (s, 3H), 
3.65-3.74 (m, 2H), 3.57-3.64 (m, 1H), 3.29-3.37 (m, 
1H), 3.15 (qt, J = 7.6 Hz, 1H), 1.80-1.88 (m, 1H), 1.67-
1.75 (m, 1H), 1.56-1.64 (m, 2H), 1.26-1.42 (m, 2H), 
1.18-1.24 (m, 1H), 0.77-0.98 (m, 29H), 0.04 (s, 12H); 
13C NMR (CDCl3, 75 MHz): δ 129.0, 113.6, 75.7, 75.3, 
72.6, 71.5, 60.5, 60.3, 55.2, 41.7, 41.4, 40.7, 40.4, 36.4, 
36.0, 35.3, 34.2, 30.8, 27.9, 27.6, 25.9, 25.8, 21.2, 21.1, 
18.4, 18.3, 15.4, 14.6, −4.3, −4.4, −4.5, −5.3. 
(3S,4R,6R,8S)-3-((tert-Butyldimethylsilyl)oxy)-9-
((4-methoxybenzyl)oxy)-4,6,8-trimethylnonan-1-ol, 
26: HF/pyridine in pyridine (4.0 mL, prepared by 
slow addition of 1.2 mL pyridine to 0.3 mL 
HF/pyridine complex, followed by dilution with  
2.5 mL THF), from the liquor solution 0.5mL  
was added to a solution of TBS ether 25 (50 mg,  
0.09 mmol) in THF (3 mL). The mixture was stirred 
overnight at RT and quenched with saturated 
NaHCO3 (10 mL). The aqueous layer was separated 
and extracted with Et2O (3×10 mL). The combined 
organic layers were washed with saturated CuSO4  
(3 × 10 mL), dried over Na2SO4, and concentrated. 
Flash column chromatography (EtOAc/hexane 1:9) 
afforded (34 mg, 85%) of alcohol 26 as colorless oil. 
1H NMR (CDCl3, 300 MHz): δ 7.25 (d, J = 6.6 Hz, 
2H), 6.87 (d, J = 8.5 Hz, 2H), 4.42 (m, 2H), 3.81  
(s, 3H), 3.66-3.78 (m, 3H), 3.28-3.38 (m, 1H),  
3.12-3.21 (m, 1H), 1.64-1.87 (m, 3H), 1.15-1.42  
(m, 2H), 0.81-0.96 (m, 22H), 0.09 (s, 3H), 0.07  
(s, 3H); 13C NMR (CDCl3, 75 MHz): δ 159.0, 130.8, 
129.0, 113.6, 75.5, 74.2, 72.6, 61.0, 55.2, 41.6, 41.2, 
39.9, 35.9, 35.6, 34.8, 32.9, 30.9, 27.7, 25.8, 21.2, 
16.0, 14.2, −4.2, −4.7. 
(3S,5S,6R,8R,10S)-5-((tert-Butyldimethylsilyl) 
oxy)-11-((4-methoxybenzyl)oxy)-2,6,8,10-tetra-
methylundecan-3-ol, 5: To a stirred solution  
of oxalyl chloride (3.7 µL, 0.044 mmol) in dry 
CH2Cl2 (2 mL) at −78°C, was added DMSO (4.5 µL, 
0.066 mmol) drop-wise under nitrogen atmosphere. 
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After 15 min stirring, a solution of alcohol 26 (10 mg, 
0.022 mmol) in 2 mL of dry CH2Cl2 was added.  
After 45 min of stirring at −78°C, Et3N (50 µL, 
0.1326 mmol) was added and the mixture was stirred 
for 0.5 h at −78°C and then for 0.5 h at 0°C. The 
mixture was then quenched with sat. NH4Cl solution 
(3 mL) and extracted with CH2Cl2 (2 × 8 mL).  
The combined organic layers were washed with  
water (5 mL), followed by brine (3 mL) solution, 
dried over Na2SO4, and concentrated in vacuo to get 
aldehyde. To a suspension of powdered Mg (2.7 mg, 
0.113 mmol) in anhydrous THF (2 mL) was added 
dropwise 2-bromopropane (2.2 µL, 0.111 mmol) 
under a dry argon atmosphere. After being stirred for 
1 h at RT, the mixture was cooled to −78°C, and a 
solution of aldehyde (10 mg, 0.022 mmol) in 
anhydrous THF (2 mL) was added drop-wise via 
cannula. The mixture was allowed to warm toRT  
and was stirred for 12 h. A saturated aqueous solution 
of NH4Cl (3 mL) was slowly added and the  
mixture was extracted with ether (15 mL). The 
organic phase was washed with brine, dried (MgSO4), 
and evaporated. The crude product was purified by 
flash chromatography (gradient, 4.5% steps, ethyl 
acetate/hexanes, 1:9 to 3:2) to give alcohol 5 (6 mg, 
55%) as a colourless oil. 1H NMR (CDCl3, 300 MHz): 
δ 7.25 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 
4.42 (m, 2H), 3.8 (s, 3H), 3.77-3.89 (m, 1H), 3.58 (bs, 
1H), 3.32 (dd, J = 9.0, 5.0 Hz, 1H), 3.16 (dd, J = 9.0, 
6.9 Hz, 1H), 2.4 (d, J = 3.5 Hz, 1H), 1.78-1.9 (m, 2H), 
1.51-1.68 (m, 3H), 1.26-1.41 (m, 5H), 0.81-0.95 (m, 
24H), 0.09 (s, 3H), 0.07 (s, 3H); 13C NMR (CDCl3, 75 
MHz): δ 158.9, 129.0, 113.6, 75.4, 73.6, 73.4, 72.6, 
55.2, 41.5, 41.3, 35.6, 34.4, 34.0, 30.9, 27.6, 25.8, 
21.3, 18.5, 18.4, 17.7, 14.6, −4.3, −4.5. 
 
Conclusion 
In summary, we have achieved the synthesis of  
C1-C11 fragment of antitumor cyclodepsipeptide 
doliculide with 6.8% overall yield in 17 longest  
linear steps starting from 12 following enzymatic 
desymmetrization, Evan’s asymmetric alkylation, 
Sharpless asymmetric epoxidation, and substrate 
controlled nucleophilic addition reactions as key 
steps. Total synthesis of doliculide and the biological 
activity of its derivatives are under study and will be 
published in due course. 
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